Is Scribe Therapeutics a good buy right now?
USNASDAQ: SCTXNASDAQ-listed
No trades yet
No trades yet on SCTX: Firefly Breakout Weekly has watched it since October 2024 without a single Buy or sell trigger.
As of 30 Sep 2026 · Firefly Breakout Weekly
Too few signals on SCTX yet to draw a chart.
Buy signals on SCTX
Oct 2024 – 30 Sep 2026No closed buy signals since October 2024.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| No closed buy signals since October 2024. | ||||
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | — |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about SCTX
SCTX share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Scribe Therapeutics. No trades yet on SCTX: Firefly Breakout Weekly has watched it since October 2024 without a single Buy or sell trigger.
How has Firefly's strategy done on Scribe Therapeutics?
It has not given a buy signal on Scribe Therapeutics between October 2024 and 30 Sep 2026.
What is the Scribe Therapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Scribe Therapeutics and how it turned out is listed on this page.
Should I sell Scribe Therapeutics?
No sell trigger is active on Scribe Therapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →